Background: The aim of this study was to investigate the relative densities of μ-, κ-, and δ-opioid receptors (MOR, KOR, and DOR) and [35S]GTPγS binding as stimulated by full agonists in mouse cerebral membranes. Methods: Naive mice (ICR, male...
http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
https://www.riss.kr/link?id=A104327939
2004
-
KCI등재,SCOPUS,SCIE
학술저널
574-579(6쪽)
0
0
상세조회0
다운로드다국어 초록 (Multilingual Abstract)
Background: The aim of this study was to investigate the relative densities of μ-, κ-, and δ-opioid receptors (MOR, KOR, and DOR) and [35S]GTPγS binding as stimulated by full agonists in mouse cerebral membranes. Methods: Naive mice (ICR, male...
Background: The aim of this study was to investigate the relative densities of μ-, κ-, and δ-opioid receptors (MOR, KOR, and DOR) and [35S]GTPγS binding as stimulated by full agonists in mouse cerebral membranes.
Methods: Naive mice (ICR, male, n = 20) were euthanized for cerebral membrane preparation. For saturation binding, [3H]DAMGO, [3H]U69593, and [3H]DPDPE were used to determine the binding parameters [Bmax (femtomoles per milligram)/Kd (nanomolar)]. And, for [35S]GTPγS stimulation binding, DAMGO, U69593, and SNC80 were used to determine EC50 (nanomolar) and maximum stimulation (% over basal) for MOR, KOR, and DOR, respectively. The Ke values of the corresponding selective antagonist, naloxone (20 nM), nor-BNI (3 nM), and naltrindole (3 nM) were also calculated.
Results: The values of Bmax and Kd for saturation binding were as follows: [3H]DAMGO (MOR; 56.4/0.92), [3H]U69593 (KOR; 23.6/1.66), and [3H]DPDPE (DOR; 71.4/3.12), and the relative proportions of MOR, KOR, and DOR were 37.3, 15.6, and 47.2%. The EC50, maximum stimulation, and the Ke value of [35S]GTPγS binding were as follows: DAMGO (MOR; 215.3/18.3/2.10), U69593 (KOR; 38.5/8.9/0.32), and SNC80 (DOR; 84.3/28.3/0.36). Bmax and maximum [35S]GTPγS binding stimulation were linearly correlated (r = 0.99).
Conclusions: The densities of three opioid receptors were found to be significantly different in mouse cerebral membrane. The amount of G protein activated by agonists were found to be directly proportional to relative receptor density. (Korean J Anesthesiol 2004; 47: 574~9)
참고문헌 (Reference)
1 Lee H, "Studies of μ-, κ-, and δ-opioid receptor densities and G protein activation in the cortex and thalamus of monkeys" 306 : 179-186, 2003
2 Mansour A, "Stimulation of guanosine-5'-O-(3-[35S]thio) triphosphate binding by endogenous opioids acting at a cloned mu receptor" 286 : 282-288, 1998
3 Liu Q, "Signal transduction correlates of mu opioid agonist intrinsic efficacy: receptor-stimulated [35S]GTPγS binding in mMOR-CHO cells and rat thalamus" 285 : 496-505, 1998
4 Craft RM, "Sex differences in opioid analgesia: "From Mouse to Man"" 19 : 175-186, 2003
5 Carter BD, "Selectivity of ligand binding to opioid receptors in brain membranes from rat, monkey and guinea pig" 148 : 343-351, 1988
6 Selley DE, "Relatioinship of m opioid receptor binding to activation of G-proteins in specific brain regions" 59 : 1395-1401, 2000
7 Bailey A, "Receptor-selective changes in μ-, δ- and κ-opioid receptors after chronic naltrexone treatment in mice." 17 : 1006-1012, 2003
8 Clark MJ, "Opioid efficacy in a C6 glioma cell line stably expressing the human kappa opioid receptor" 288 : 827-833, 1999
9 Emmerson PJ, "Opioid efficacy in a C6 glioma cell line stably expressing the delta opioid receptor" 283 : 501-510, 1997
10 Nahorski SR, "Modulation by mu-opioid agonists of guanosine-5'-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells" 47 : 848-854, 1994
1 Lee H, "Studies of μ-, κ-, and δ-opioid receptor densities and G protein activation in the cortex and thalamus of monkeys" 306 : 179-186, 2003
2 Mansour A, "Stimulation of guanosine-5'-O-(3-[35S]thio) triphosphate binding by endogenous opioids acting at a cloned mu receptor" 286 : 282-288, 1998
3 Liu Q, "Signal transduction correlates of mu opioid agonist intrinsic efficacy: receptor-stimulated [35S]GTPγS binding in mMOR-CHO cells and rat thalamus" 285 : 496-505, 1998
4 Craft RM, "Sex differences in opioid analgesia: "From Mouse to Man"" 19 : 175-186, 2003
5 Carter BD, "Selectivity of ligand binding to opioid receptors in brain membranes from rat, monkey and guinea pig" 148 : 343-351, 1988
6 Selley DE, "Relatioinship of m opioid receptor binding to activation of G-proteins in specific brain regions" 59 : 1395-1401, 2000
7 Bailey A, "Receptor-selective changes in μ-, δ- and κ-opioid receptors after chronic naltrexone treatment in mice." 17 : 1006-1012, 2003
8 Clark MJ, "Opioid efficacy in a C6 glioma cell line stably expressing the human kappa opioid receptor" 288 : 827-833, 1999
9 Emmerson PJ, "Opioid efficacy in a C6 glioma cell line stably expressing the delta opioid receptor" 283 : 501-510, 1997
10 Nahorski SR, "Modulation by mu-opioid agonists of guanosine-5'-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells" 47 : 848-854, 1994
11 Kastin AJ, "Endogenous opiates" 22 : 2257-2328, 2000
12 Butelman ER, "Differentiation of kappa opioid agonist-induced antinociception by naltrexone apparent pA2 analysis in rhesus monkeys" 285 : 518-526, 1998
13 Naughton NN, "Differential densities of mu, kappa, and delta opioid receptors and their receptor-G protein interactions in the thalamus and spinal cord of monkeys" 96 : A792-, 2002
14 Rodriguez FD, "Characterization of kappa-opioid binding sites in rat and guinea-pig spinal cord" 28 : 1041-1046, 1989
15 Liu M-R, "Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes" 271 : 1630-1637, 1994
16 Khachaturian H, "Anatomy of CNS opioid receptors" 11 : 308-314, 1988
17 Kim KW, "A study on the dural variation of endorphin in rat brain" 20 : 35-47, 1984
18 Bradford MM, "A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding" 72 : 248-254, 1976
혈당과 동맥혈 가스분석 및 폐포-동맥혈 산소분압차에 의한당뇨병이 수술 전후 환자 상태에 미치는 영향의 평가
경막외 마취시 시험용량에 포함된 Epinephrine의Ropivacaine 작용에 미치는 영향
개흉술 후 통증관리를 위한 Ropivacaine의 흉부 경막외지속 주입시 Sufentanil의 적정 병용 용량
척추수술 후 통증증후군 환자에서 경막외 유착용해술의 임상 경험
학술지 이력
연월일 | 이력구분 | 이력상세 | 등재구분 |
---|---|---|---|
2023 | 평가예정 | 해외DB학술지평가 신청대상 (해외등재 학술지 평가) | |
2020-01-01 | 평가 | 등재학술지 유지 (해외등재 학술지 평가) | ![]() |
2013-11-27 | 학회명변경 | 한글명 : 대한마취과학회 -> 대한마취통증의학회 | ![]() |
2011-01-01 | 평가 | 등재학술지 유지 (등재유지) | ![]() |
2010-07-20 | 학술지명변경 | 한글명 : 대한마취과학회지 -> Korean Journal of Anesthesiology | ![]() |
2009-01-01 | 평가 | 등재학술지 유지 (등재유지) | ![]() |
2007-01-01 | 평가 | 등재 1차 FAIL (등재유지) | ![]() |
2004-01-01 | 평가 | 등재학술지 선정 (등재후보2차) | ![]() |
2003-01-01 | 평가 | 등재후보 1차 PASS (등재후보1차) | ![]() |
2001-07-01 | 평가 | 등재후보학술지 선정 (신규평가) | ![]() |
학술지 인용정보
기준연도 | WOS-KCI 통합IF(2년) | KCIF(2년) | KCIF(3년) |
---|---|---|---|
2016 | 0.09 | 0.09 | 0.1 |
KCIF(4년) | KCIF(5년) | 중심성지수(3년) | 즉시성지수 |
0.09 | 0.09 | 0.27 | 0.01 |